Skip Navigation



Rheumatology Advance Access published online on July 30, 2003

Rheumatology, doi:10.1093/rheumatology/keg443
Rheumatology © British Society for Rheumatology 2003; all rights reserved
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/1/22    most recent
keg443v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ravindran, J. S.
Right arrow Articles by McHugh, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ravindran, J. S.
Right arrow Articles by McHugh, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Rheumatology 42 © British Society for Rheumatology 2003; all rights reserved

Original Papers

Interleukin 1{alpha}, interleukin 1{beta} and interleukin 1 receptor gene polymorphisms in psoriatic arthritis

J. S. Ravindran 1, P. Owen 1, A. Lagan 2, J. Lewis 1, E. Korendowych 1, K. Welsh 2, and N. McHugh 1*

1 Royal National Hospital for Rheumatic Diseases and Department of Medical Sciences, University of Bath, Bath, UK
2 National Heart and Lung Institute, Imperial College of Science and Medicine, 1B Manresa Road, London, UK

* Corresponding author. E-mail: N.J.McHugh{at}bath.ac.uk.

Received 7 February 2003 ; accepted 16 May 2003

Abstract

Objectives. To investigate polymorphisms of interleukin (IL) 1{alpha}, IL-1{beta} and IL-1 receptor R1 genes in patients with psoriatic arthritis (PsA), their relationship to the age of onset of psoriasis and the pattern of joint involvement.

Methods. One hundred and forty well-characterized patients with PsA were studied. One hundred healthy controls were recruited from primary care. All were genotyped for single-nucleotide polymorphisms in the genes for IL-1{alpha} (position -889), IL-1{beta} (position +3953) and IL-1R1 (position +970). The frequencies of the respective variants were compared between patients and controls and in relation to age of onset of psoriasis, to clinical subsets of the disease and to the presence of erosions.

Results. All three polymorphisms were in Hardy-Weinberg equilibrium in both patients and controls. The frequency of IL-1{alpha} -889 CC homozygotes was significantly increased in PsA patients compared with normal controls [58 vs 40%, odds ratio (OR) 2.06, 95%, confidence interval (CI) 1.22-3.47]. The frequency of the IL-1{alpha} -889 C allele was significantly increased in PsA patients compared with controls (75 vs 65%, OR 1.65, 95% CI 1.11-2.45). In subset analysis there were no other significant differences in allelic frequencies for the IL-1{alpha} -889 C/T, IL-1{beta} +3953 C/T and IL-1R1 +970 C/T polymorphisms.

Conclusions. The IL-1 gene complex may play a role in the development of PsA and/or psoriasis or act as a marker for other genes on chromosome 2q12 to 2q13.

Key words: Psoriatic arthritis, Cytokine gene, Interleukin 1.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
haematolHome page
K. Hatta, A. Morimoto, E. Ishii, H. Kimura, I. Ueda, S. Hibi, S. Todo, T. Sugimoto, and S. Imashuku
Association of transforming growth factor-{beta}1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases
Haematologica, November 1, 2007; 92(11): 1470 - 1474.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.